During his more than ten years at Cabot, Michael Cintolo has uncovered exceptional growth stocks and helped to create new tools and rules for buying and selling stocks. Perhaps most notable was his development of the proprietary trend-following market timing system, Cabot Tides, which has helped Cabot place among the top investment newsletters numerous times. Cabot Growth Investor has been consistently recognized for outstanding performance by Hulbert Financial Digest and Timer Digest. It is one of Hulbert's top five newsletters for five-year risk-adjusted performance with a 13.2% annualized return as of June 30, 2011. It is also ranked among the Top Ten Newsletters by Timer Digest for long-term performance.
The wild rotation that has been a hallmark of 2021 has returned, with money racing into cyclical areas; we’re still sticking with a stock-by-stock approach — such as these energy ideas, explains Mike Cintolo, growth stock specialist and editor of Cabot Top Ten Trader.
Catalent (CTLT) has played an outsized role in the race to produce Covid vaccines. It’s a contract manufacturer that helps pharmaceutical customers develop biologic drugs and gene therapies, notes Mike Cintolo, growth stock expert and editor of Cabot Top Ten Trader.
The legal American cannabis market grew 50% during the last couple of years and is seen more than doubling by 2025 to become a $46 billion market, reports Mike Cintolo, growth expert and editor of Cabot Top Ten Trader.
“Death of storefront retail” predictions have proven elusive as shoppers have swarmed malls during the economic reopening and hard-on-their-luck retailers have made moves to survive — and even thrive, notes Mike Cintolo, editor of Cabot Top Ten Trader.